Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys)
about
Identification of critical elements in the tRNA acceptor stem and T(Psi)C loop necessary for human immunodeficiency virus type 1 infectivityEfficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidationPreferences for the selection of unique tRNA primers revealed from analysis of HIV-1 replication in peripheral blood mononuclear cellsPrimer tRNAs for reverse transcriptionSelection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication.It Is Imperative to Establish a Pellucid Definition of Chimeric RNA and to Clear Up a Lot of Confusion in the Relevant Research.The nucleocapsid protein specifically anneals tRNALys-3 onto a noncomplementary primer binding site within the HIV-1 RNA genome in vitro.Interactions between Ty1 retrotransposon RNA and the T and D regions of the tRNA(iMet) primer are required for initiation of reverse transcription in vivo.Structural basis for the specificity of the initiation of HIV-1 reverse transcription.Functional recognition of the modified human tRNALys3(UUU) anticodon domain by HIV's nucleocapsid protein and a peptide mimic.Effect of altering the tRNA(Lys)(3) concentration in human immunodeficiency virus type 1 upon its annealing to viral RNA, GagPol incorporation, and viral infectivity.The leader of the HIV-1 RNA genome forms a compactly folded tertiary structureInhibition of human immunodeficiency virus type 1 replication with artificial transcription factors targeting the highly conserved primer-binding site.The primer binding site on the RNA genome of human and simian immunodeficiency viruses is flanked by an upstream hairpin structure.Mutational analysis of the tRNA3Lys/HIV-1 RNA (primer/template) complex.The Interaction between tRNA(Lys) 3 and the primer activation signal deciphered by NMR spectroscopy.Effects of modifying the tRNA(3Lys) anticodon on the initiation of human immunodeficiency virus type 1 reverse transcriptionHuman immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding siteThe importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity.Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1.Nucleotide substitutions within U5 are critical for efficient reverse transcription of human immunodeficiency virus type 1 with a primer binding site complementary to tRNA(His)Placement of tRNA primer on the primer-binding site requires pol gene expression in avian but not murine retroviruses.Anti HIV-1 virucidal activity of polyamide nucleic acid-membrane transducing peptide conjugates targeted to primer binding site of HIV-1 genomeForced selection of tRNA(Glu) reveals the importance of two adenosine-rich RNA loops within the U5-PBS for SIV(smmPBj) replication.The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA.TRIM28 mediates primer binding site-targeted silencing of Lys1,2 tRNA-utilizing retroviruses in embryonic cellsNew insights into inhibition of human immunodeficiency virus type 1 replication through mutant tRNALys3.Prospects for antisense peptide nucleic acid (PNA) therapies for HIVFrequent dual initiation in human immunodeficiency virus-based vectors containing two primer-binding sites: a quantitative in vivo assay for function of initiation complexes.Destabilization of tRNA3(Lys) from the primer-binding site of HIV-1 genome by anti-A loop polyamide nucleotide analogTat is required for efficient HIV-1 reverse transcription.Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer.Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His).HIV-1 designed to use different tRNAGln isoacceptors prefers to select tRNAThr for replication.Initiation of HIV Reverse TranscriptionComplementation of human immunodeficiency virus type 1 replication by intracellular selection of Escherichia coli formula supplied in trans.Genetic analysis of a unique human immunodeficiency virus type 1 (HIV-1) with a primer binding site complementary to tRNAMet supports a role for U5-PBS stem-loop RNA structures in initiation of HIV-1 reverse transcriptionPreferential completion of human immunodeficiency virus type 1 proviruses initiated with tRNA3Lys rather than tRNA1,2Lys.Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses.Transfer of primer binding site-mutated simian immunodeficiency virus vectors by genetically engineered artificial and hybrid tRNA-like primers.
P2860
Q24529117-FDACF01D-A954-4D31-AF43-B14ABF6C50B9Q24673792-F4FFB837-AE77-4C4D-9794-69C775DC662BQ24791889-F55FCD9F-841D-4177-B55A-6AC16A8772B6Q28775697-725D1E10-4CFC-478D-B891-7998B2CF0822Q30651852-C1FA863F-610B-41EC-8D37-0B66977573BCQ33624325-EBF0C704-E050-422D-975E-0DD0C2AADB0AQ33709362-A6C6CC1B-B098-4EA7-BCA8-DB824CCCDA9AQ33770933-7A0A64BD-13E9-4C9B-B3EC-2E1524968728Q33890456-BFA8ADCD-8A81-4EDD-8D90-113C78821195Q33962718-B3B94C7B-B318-4DDB-A589-8AFA67AEAEB3Q34344599-6A23F2EE-62A8-4A32-9ED2-5B6A03130140Q34362436-EFF40A90-7612-4CD0-B1B1-9DCA348117B4Q34434986-2C691C9E-6F47-428D-9E8A-C3C0514C0E50Q34639614-171F6AEB-BB4E-468B-A71D-F6E8E025438BQ34658242-0ED8795C-C681-4CB0-AB1C-40BCE79A1682Q34769447-F98EDF06-266F-41AD-82D2-9DADD9863FC6Q35864780-B1294353-69FE-4DAA-A027-17431E11FC0DQ35865776-06BA1035-DD7A-43B2-AAF2-44433A9EA636Q35889392-ACDCB994-95DD-4D20-B943-A674D6094F4DQ35890003-F052260C-C240-415C-B34E-912E1E1EFDCAQ35890905-0C12786C-5076-4987-8D5A-80AE22533F4FQ35892473-890078B6-77E7-4638-9B7B-EB5A46D838F4Q36086779-6B6076DC-169C-436E-8C1D-3E4DB33C6676Q36088903-0828A675-4584-4423-B115-393EED53B6B9Q36548610-F73C8366-1513-46DA-94E2-1E6FEC284DB8Q36841416-E749E716-E82E-4D75-85EE-0DA6F68B7A3CQ37320502-50F0BD45-3168-4117-B8B4-CD55E9963BAEQ37473797-07BF7B42-C675-4D32-8BDD-5B5F24D50471Q37730594-2E5A74E6-E55F-48EB-8654-1D0921324738Q38292600-C8B3659D-7B7C-48DB-9D5A-EF31C1426968Q38347693-0BE2FC1F-8FBF-45FA-9E0D-A2E6576598F0Q38349052-A0883C8E-E018-4075-8EF2-F7E883FA55B2Q38362410-55F8362F-9105-4DB5-8EF8-BB25153FA991Q38394900-11B02292-B952-4ACB-84B3-99F75561C55BQ38613919-C33CE538-CEF5-4066-B956-3C2F583439B7Q38760919-C972DFF8-01F6-470F-87D9-FC1D1755F2BFQ39551629-CA8FC20E-8181-4CCF-A4ED-42A0CDAB92B0Q39581407-AA78071B-0F22-43B8-B3E5-E4F1B2E63C38Q39594951-8420801C-16C0-494C-A424-E14E643BB3A8Q39602865-5BD937C1-761E-4ED6-9BDA-44679EDEA681
P2860
Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys)
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Human immunodeficiency virus t ...... te complementary to tRNA(3Lys)
@ast
Human immunodeficiency virus t ...... te complementary to tRNA(3Lys)
@en
type
label
Human immunodeficiency virus t ...... te complementary to tRNA(3Lys)
@ast
Human immunodeficiency virus t ...... te complementary to tRNA(3Lys)
@en
prefLabel
Human immunodeficiency virus t ...... te complementary to tRNA(3Lys)
@ast
Human immunodeficiency virus t ...... te complementary to tRNA(3Lys)
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus t ...... te complementary to tRNA(3Lys)
@en
P2093
C D Morrow
J K Wakefield
P2860
P304
P407
P577
1995-10-01T00:00:00Z